Liver steatosis is the most common parenchymal liver disease in Western Countries and it may progress to steatohepatis, fibrosis and cirrhosis. Also, fat deposition in liver and pancreas can cause diabetes by increasing resistance to insulin. Magnetic Resonance Spectroscopy (MRS) has been shown to strongly correlate with histology in liver fat quantification. However, MRS has some limitations such as breathing artifact and difficulties in avoiding vessels or bile ducts within the voxel. So, it is desirable to utilize a novel and robust imaging technique that can screen for the presence of fat in the liver and pancreas.